Kissei Pharmaceutical Co. Ltd
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
8/10
|
14.05 | 0 | 0% | 304.71 | -95.39% |
| P/S |
|
2.07 | 0 | 0% |
|
|
| P/BV |
|
0.709 | 0 | 0% |
|
|
| P/FCF |
|
0 | 0 | 0% |
|
|
| Ev/Ebitda |
|
7.22 | 0 | 0% |
|
|
| Ev/S |
|
1.79 | 0 | 0% |
|
|
| Ev/FCF |
|
-38.53 | 0 | 0% |
|
|
| E/P |
|
0 | 0 | 0% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
7/10
|
24.77 | 0 | 0% | 12.85 | +92.81% |
| ROE |
|
10.08 | 0 | 0% |
|
|
| ROA |
|
8.5 | 0 | 0% |
|
|
| ROIC |
|
0 | 0 | 0% |
|
|
| ROS |
|
14.77 | 0 | 0% |
|
|
| ROCE |
|
6.54 | 0 | 0% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
0.0716 | 0 | 0% | 0.4321 | -83.44% |
| Nеt Debt/Ebitda |
|
-1.15 | 0 | 0% |
|
|
| Debt/Ratio |
|
0.0051 | 0 | 0% |
|
|
| Debt/Equity |
|
0 | 0 | 0% |
|
|
| Debt/Net Income |
|
0.1201 | 0 | 0% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
9.43/10
|
3.77 | 0 | 0% | 147.31 | -97.44% |
| Number of years of dividend growth |
|
0 | 0 | 0% | ||
| DSI |
|
0.8571 | 0 | 0% |
|
|
| Average dividend growth |
|
-652.62 | 0 | 0% |
|
|
| Average percentage for 5 years |
|
147.31 | 0 | 0% |
|
|
| Average percentage for payments |
|
764.61 | 0 | 0% |
|
|
| Difference from average difference in sector |
|
3.77 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
12800.83 | 0 | 0% | ||
| Growth impulse Ebitda in 5 years |
|
45634.91 | 0 | 0% | ||
| Growth impulse Net Income in 5 years |
|
42668.12 | 0 | 0% | ||
| Growth impulse FCF in 5 years |
|
-3224.1 | 0 | 0% | ||
| Growth impulse EPS in 5 years |
|
711.78 | 0 | 0% |
IP Score
6.89/10
